REPLIGEN CORPREPLIGEN CORPREPLIGEN CORP

REPLIGEN CORP

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
0.28EUR
Revenue estimate
‪139.08 M‬EUR
Market capitalization
‪8.64 B‬EUR
‪37.67 M‬EUR
‪578.73 M‬EUR
‪51.85 M‬
Beta (1Y)
2.57

About Repligen Corporation

CEO
Tony J. Hunt
Headquarters
Waltham
Employees (FY)
‪1.78 K‬
Founded
1981
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RGN is 155.50 EUR — it has increased by 0.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange REPLIGEN CORP stocks are traded under the ticker RGN.
REPLIGEN CORP is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
RGN stock is 0.78% volatile and has beta coefficient of 2.57. Check out the list of the most volatile stocks — is REPLIGEN CORP there?
RGN earnings for the last quarter are 0.22 EUR per share, whereas the estimation was 0.16 EUR resulting in a 39.51% surprise. The estimated earnings for the next quarter are 0.30 EUR per share. See more details about REPLIGEN CORP earnings.
REPLIGEN CORP revenue for the last quarter amounts to ‪133.57 M‬ EUR despite the estimated figure of ‪133.09 M‬ EUR. In the next quarter revenue is expected to reach ‪140.78 M‬ EUR.
Yes, you can track REPLIGEN CORP financials in yearly and quarterly reports right on TradingView.
RGN stock has risen by 4.78% compared to the previous week, the month change is a 8.64% fall, over the last year REPLIGEN CORP has showed a 17.45% increase.
RGN net income for the last quarter is ‪−23.09 M‬ EUR, while the quarter before that showed ‪17.19 M‬ EUR of net income which accounts for −234.33% change. Track more REPLIGEN CORP financial stats to get the full picture.
Today REPLIGEN CORP has the market capitalization of ‪8.64 B‬, it has decreased by 4.37% over the last week.
No, RGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REPLIGEN CORP stock right from TradingView charts — choose your broker and connect to your account.
RGN reached its all-time high on Sep 27, 2021 with the price of 291.38 EUR, and its all-time low was 1.09 EUR and was reached on Jul 26, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 30, 2024, the company has ‪1.78 K‬ employees. See our rating of the largest employees — is REPLIGEN CORP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REPLIGEN CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REPLIGEN CORP stock shows the neutral signal. See more of REPLIGEN CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on REPLIGEN CORP future price: according to them, RGN price has a max estimate of 215.11 EUR and a min estimate of 168.35 EUR. Read a more detailed REPLIGEN CORP forecast: see what analysts think of REPLIGEN CORP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REPLIGEN CORP EBITDA is ‪117.86 M‬ EUR, and current EBITDA margin is 20.57%. See more stats in REPLIGEN CORP financial statements.